source
- Eli Lilly suggests low-dose Zepbound and Foundayo could safely maintain weight loss at lower costNew trial data indicate that lowering the dose of Eli Lilly's obesity injection Zepbound may still provide effective weight‑loss maintenance while improving safety. The study also highlights Found…
- EU Parliament and Council provisionally approve Critical Medicines Act to strengthen drug supply chainsThe European Parliament and the Council have provisionally voted to adopt the Critical Medicines Act, marking a key step toward its implementation. The legislation is designed to reinforce the EU’…